1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. China Isotope & Radiation Corporation
  6. Company
    1763   CNE1000031F4

CHINA ISOTOPE & RADIATION CORPORATION

(1763)
  Report
Delayed Hong Kong Stock Exchange  -  05/27 04:08:54 am EDT
19.38 HKD   +0.41%
05/23China Isotope & Radiation Corporation Announces Final Ordinary Dividend for the Financial Year End 31 December 2021, Payable on July 22, 2022
CI
04/19China Isotope & Radiation Corporation Proposes Final Dividend for 2021, Payable Before 23 July 2022
CI
03/30China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
China Isotope & Radiation Corporation is a China-based company principally engaged in the research, development, manufacture and sales of radiopharmaceuticals for the diagnosis and treatment of radiopharmaceuticals, as well as medical and industrial radioactive source products. The Company also provides radiation sterilization services. The Company is also involved in the design, manufacture and installation of Gama ray irradiation devices. The Company opeartes its businesse mainly through four segments, including the Pharmaceuticals segment, the Radiological Products segment, the Irradiation segment and the Independent Medical Laboratory Services and Others segment, with the Pharmaceuticals segment as the core segment. The Pharmaceuticals segment is engaged in the development, manufacture and sale of radiopharmaceuticals, the Kit for Urea Breath Test and testing instruments, as well as in vitro immunodiagnostic reagents and boxes for imaging diagnosis and treatment.

Number of employees : 3 120 people.
Sales per Business
20202021Delta
Pharmaceuticals3 348.1469.7%4 523.6073% +35.11%
Radioactive Source Products507.9810.6%626.9110.1% +23.41%
Radiation Therapy Equipments and Related Services258.855.4%470.047.6% +81.59%
Independent Clinical Laboratory Services and Other572.6011.9%404.996.5% -29.27%
Irradiation115.322.4%173.712.8% +50.64%
HKD in Million
Sales per region
20202021Delta
China4 802.87100%6 199.24100% +29.07%
HKD in Million
Managers
Name Title Age Since
Suo Hui Wang General Manager & Executive Director 46 2021
Mei Ha Kam Joint Secretary 53 -
You Quan Gui Joint Secretary & Chief Accountant 47 2020
Jin Du, Dr. Chief Engineer 56 2016
Lai Shui Wu Chief Accounting & Legal Officer 47 2020
Members of the board
Name Title Age Since
Yan Bin Meng Chairman 52 2017
Qing Jun Zhang Chairman-Supervisory Board 50 2017
Qing Liang Guo Independent Non-Executive Director 65 2017
Yan Meng, Dr. Independent Non-Executive Director 66 2017
Wan Fai Hui Independent Non-Executive Director 44 2018
Jiahe Tian Independent Non-Executive Director 70 2019
Jing Shan Chen Independent Non-Executive Director 51 2021
Chuang Lu, Dr. Independent Non-Executive Director 41 2021
Jian Wu Executive Director 58 2020
Jin Du, Dr. Chief Engineer 56 2016
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 79,968,800 28,158,800 35.2% 0 0.0% 83.1%
Stock B 1 239,906,100 237,507,039 99.0% 0 0.0%
Shareholders
NameEquities%
Hong Bo Li 15,233,400 19.0%
Beijing State-Owned Assets Supervision & Administration 10,899,000 13.6%
Shanghai Industrial Holdings Limited 9,516,600 11.9%
Invesco Canada Ltd. 8,985,000 11.2%
Invesco Advisers, Inc. 8,812,000 11.0%
Shanghai Pharmaceuticals Holding Co., Ltd 8,006,000 10.0%
FIL Investment Management (Hong Kong) Ltd. 6,135,400 7.67%
Serenity Capital Management Ltd. (Cayman Islands) 4,801,600 6.00%
Postal Savings Bank of China Co., Ltd. 3,981,600 4.98%
Invesco Hong Kong Ltd. 2,137,400 2.67%
Company contact information
China Isotope & Radiation Corp.
No. 1 Nansixiang
Sanlihe
Xicheng District
Beijing 100045

Phone : +86.10.68522774
Fax : +86.10.68512374
Web : http://www.china-isotope.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of China Isotope & Radiation Corporation
Sector Pharmaceuticals
1st jan.Capi. (M$)
CHINA ISOTOPE & RADIATION CORPORATION-11.91%790
JOHNSON & JOHNSON5.86%472 231
PFIZER, INC.-8.70%302 932
ROCHE HOLDING AG-12.16%282 336
ELI LILLY AND COMPANY17.11%282 164
ABBVIE INC.10.78%266 074
NOVO NORDISK A/S-3.80%242 093
MERCK & CO., INC.20.45%233 434
ASTRAZENECA PLC21.92%205 677
NOVARTIS AG4.56%198 211
BRISTOL-MYERS SQUIBB COMPANY22.12%165 194
SANOFI15.58%138 769
AMGEN INC.13.46%135 179
GSK PLC7.88%111 724
CSL LIMITED-7.17%92 001
MERCK KGAA-21.50%81 807
ZOETIS-29.48%78 077
BAYER AG41.66%69 450
DAIICHI SANKYO CO., LTD.18.36%52 109
SAMSUNG BIOLOGICS CO.,LTD.-7.64%47 349
TAKEDA PHARMACEUTICAL COMPANY LIMITED19.92%45 598